Health
Maker seeking Indian trial of Novavax jab – 7NEWS.com.au
Vaccine maker, the Serum Institute of India, wants to trial the Novavax jab locally, to factor in genetic differences in its population.
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
General11 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News14 hours agoSanta drops in for carols
-
General17 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Business16 hours agoHow much upside does Macquarie predict for Sonic Healthcare shares?